Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, October 13, 2014
Oral afatinib significantly improves progression-free survival in patients with head and neck cancer
›
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurre...
Sunday, October 12, 2014
Isavuconazole demonstrates successful outcomes in treatment of mucormycosis
›
In continuation of my update on Isavuconazole Isavuconazole demonstrates successful outcomes in treatment of mucormycosis
Friday, October 10, 2014
Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting
›
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial p...
Thursday, October 9, 2014
Crizotinib drug effectively halts growth of ROS1-positive lung tumors
›
In continuation of my update on crizotinib Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tu...
FDA Approves Iluvien for Diabetic Macular Edema
›
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that th...
1 comment:
Wednesday, October 8, 2014
Candidate H7N9 avian flu vaccine works better with adjuvant
›
Candidate H7N9 avian flu vaccine works better with adjuvant
Researchers Discover How Bacteria Resist Antibiotics in Hospitals
›
Tiny circles of DNA called plasmids appear to be the culprit. They can easily enter bacteria and move from one bacteria to another, and so...
Tuesday, October 7, 2014
FDA Approves Triumeq for the Treatment of HIV-1 Infection
›
In continuation of my update on Triumeq ViiV Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approve...
FDA Approves Contrave (bupropion/naltrexone) for Weight Management
›
In continuation of my update on bupropion/naltrexone The U.S. Food and Drug Administration today approved Contrave (naltrexone hydr...
Monday, October 6, 2014
The Nobel Prize in Physiology or Medicine 2014
›
The Nobel Prize in Physiology or Medicine 2014
FDA Approves Otezla (apremilast) for Moderate to Severe Plaque Psoriasis
›
In continuation of my update on Apremilast (brand name Otezla ) is an orally available small molecule inhibitor of phosphodiesterase 4...
FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD
›
We know that, Tiotropium bromide , is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic o...
Friday, October 3, 2014
FDA Approves Vitekta (elvitegravir) for HIV-1 Infection
›
We know that, Elvitegravir ( EVG , formerly GS-9137 ) is a drug used for the treatment of HIV infection. It acts as an integrase inh...
Thursday, October 2, 2014
Scripps Research Institute Chemists Modify Antibiotic to Vanquish Resistant Bacteria
›
Scientists at The Scripps Research Institute (TSRI) have devised a new antibiotic based on vancomycin that is powerfully effective against...
Wednesday, October 1, 2014
FDA Approves Tybost (cobicistat) for use in the treatment of HIV-1 Infection
›
We know that, Cobicistat (formerly GS-9350) is a licensed drug for use in the treatment of infection with the human immunodeficiency ...
‹
›
Home
View web version